The intranuclear disposition of plasmid DNA is highly important for transgene expression. The effects of a left-handedly curved sequence with high histone affinity on transgene expression were examined in COS-7 cells with two kinds of carriers (Lipofectamine Plus and TransIT-LT1).
Introduction
Plasmid DNAs, in either the naked or complexed form, have been used for transgene expression with nonviral vectors in gene therapy and biotechnology (Mahato et al., 1997; Rolland, 1998; Kamiya et al., 2001 Kamiya et al., , 2003 Niidome and Huang, 2002) . The intranuclear disposition of the plasmid DNA is a key factor in efficient transgene expression (Kamiya et al., 2003) . Improvements in both the intranuclear disposition of the plasmid DNA and intracellular trafficking are required, for overcoming the low transgene expression efficiency of nonviral vectors in comparison to that of viral vectors. In addition, transgene expression was found to be transient due to a decrease in the transcription efficiency (Herweijer et al., 2001; Chen et al., 2003 Chen et al., , 2004 Pringle et al., 2005; Ochiai et al., 2006a Ochiai et al., , 2006b Ochiai et al., , 2007 , although prolonged transgene expression was described in some cases (Stoll et al., 2001 , Yew et al., 2002 Aliño et al., 2003; Chen et al., 4 Thus, the interaction(s) between the plasmid DNA and the histone proteins seem to be quite important for efficient transgene expression.
Previously, Nishikawa et al. (2003) reported that TCAGTTTTT [CATGTTTTT] 3 (left-handedly curved DNA, T4), with the appropriate combination of distance and spatial positioning, could activate a eukaryotic promoter when delivered in a naked form into cultured COS-7
cells. This finding prompted us to examine the effects of this left-handedly curved sequence on transgene expression from plasmid DNAs delivered with carriers in COS-7 cells. In this study, we investigated the effects of this sequence on plasmid DNAs delivered by two commercially available transfection reagents, Lipofectamine Plus (referred to as Lipofectamine, hereafter) and TransIT-LT1, as models. We found that plasmid DNAs containing the T4 sequence at appropriate positions also activated transgene expression, when introduced in a complexed form. Interestingly, however, the effects of the distance between the T4 sequence and the TATA box (the core promoter sequence) were different from those when the naked plasmid DNAs were delivered. In addition, the degree of the enhancement was dependent on the carriers used. These results indicate that the T4 sequence is an effective functional sequence to control the intranuclear disposition of plasmid DNAs, and that carriers affect the intranuclear disposition. 
Materials and methods

Materials
Oligodeoxyribonucleotides were purchased from Sigma Genosys Japan (Ishikari, Japan) in purified forms. The pST0/TLN-7, pLHC4/TLN+47, pLHC4/TLN-16, and pLHC4/TLN-6 plasmids, containing the thymidine kinase (tk) promoter and the luciferase gene ( Fig.   1 ) (Nishikawa et al., 2003) , were amplified in Escherichia coli and purified with a Qiagen (Hilden, Germany) EndoFree Plasmid Mega kit. 
Transfection
Statistical analysis
Statistical significance was examined by the Student's t-test.
Levels of P<0.05 were considered to be significant. At 24 hr after transfection initiation, the luciferase expression from pLHC4/TLN-16 and pLHC4/TLN-6 seemed to be higher than that from pST0/TLN-7, the control plasmid, and the difference between pLHC4/TLN-16 and pST0/TLN-7 was statistically significant ( Fig. 2A) . At 48-96 hr, the luciferase activity was significantly higher for pLHC4/TLN-16 and pLHC4/TLN-6 than for pST0/TLN-7 ( Fig We then quantitated the amounts of the exogenous DNAs by Q-PCR (Table 1, upper panel) . The amounts of the DNAs were broadly equal at each time point, and no tendency was observed for the amounts of the DNAs. These results suggest that the location of the T4 sequence did not affect the amounts of the plasmid DNAs.
Results
Effects of the left-handedly curved sequence on gene expression from plasmid DNAs delivered with Lipofectamine
Effects of the left-handedly curved sequence on gene expression from plasmid DNAs delivered with TransIT-LT1
Next, we delivered the plasmid DNAs with TransIT-LT1, a protein/polyamine-based reagent that contains histone and a unique lipid, and examined the luciferase activities and the amounts of exogenous DNA.
As shown in Fig. 3 , the luciferase activity was significantly higher for pLHC4/TLN-16 and pLHC4/TLN-6 than for pST0/TLN-7, except for pLHC4/TLN-6 at 24 hr. On the other hand, the expression from pLHC4/TLN+47 seemed lower than that from the control plasmid at 24, 72
and 96 hr, and significantly lower at 48 hr. As in the case of Lipofectamine, and in contrast to the case of electroporation, the transgene expression from pLHC4/TLN-16 and pLHC4/TLN-6 was similar. The enhancement in the luciferase expression from these plasmid DNAs was 5.5-to 7.7-fold larger than that from pST0/TLN-7 at 24, 48, and 96 hr, and 14.9-and 13.7-fold (for pLHC4/TLN-16 and pLHC4/TLN-6, respectively) at 72 hr. The effects of the T4 sequence were more evident with the TransIT-LT1 reagent than with Lipofectamine (Figs. 2 and 3 ).
The amounts of the DNAs were broadly equal at each time point, and no tendency was observed for the amounts of the DNAs (Table 1, lower panel). These results suggest that the location of the T4 sequence did not affect the amounts of plasmids, as in the case of Lipofectamine. 
Expression efficiency
We calculated the expression efficiencies for the plasmid DNAs used in this study. The luciferase activities at 24-96 hr were divided by the amounts of the exogenous DNAs at the same time points. As expected, the expression efficiencies of pLHC4/TLN-16 and pLHC4/TLN-6 were higher than those of pST0/TLN-7 and pLHC4/TLN+47 (Table 2) .
Interestingly, at 48 hr, the expression efficiency from pLHC4/TLN-16 was 2-fold higher with Lipofectamine than with
TransIT-LT1 (statistically significant, P<0.05). In contrast, the efficiency was similar in the case of pLHC4/TLN-6 at the same time point. In addition, the expression efficiencies from pLHC4/TLN-6 and pLHC4/TLN-16 relative to that from pST0/TLN-7 were larger in the case of TransIT-LT1, as compared to Lipofectamine, at 72 hr. The TransIT-LT1 reagent contains histone (although the details are proprietary) and this may be related to this observation.
Discussion
Previously These results raised the question of whether the effects of the T4 sequence could be observed when these plasmid DNAs are delivered by carriers. In this study, we transfected the pLHC4/TLN-6, pLHC4/TLN-16, and pLHC4/TLN+47 plasmids into COS-7 cells. We also examined the pST0/TLN-7 plasmid, containing the straight sequence instead of the T4 sequence, as a control. These plasmid DNAs were introduced with two commercially available transfection reagents, Lipofectamine and
TransIT-LT1, as models.
In this study, we observed that the T4 sequence also increased transgene expression in COS-7 cells in a distance-dependent manner (Figs.
12 luciferase gene revealed that pLHC4/TLN-6 produced luciferase ~2-fold more efficiently than pLHC4/TLN-16 at 24 hr after transfection with the Lipofectamine and TransIT-LT1 reagents (Table 2) . This result was similar to the observation in the previous study that the expression of the luciferase gene from the former plasmid was ~2-fold higher than that from the latter plasmid at 21 hr after electroporation (Nishikawa et al., 2003) .
However, different tendencies were also observed between the previous study and this one. The luciferase gene was expressed in the order of pLHC4/TLN-6 > pLHC4/TLN-16 at 21 hr after delivery in a naked form (Nishikawa et al., 2003) . On the other hand, the luciferase protein was produced from pLHC4/TLN-6 and pLHC4/TLN-16 with similar efficiencies at 48-96 hr, when transfected with the carriers used in this study (Figs. 2 and 3 ). Further studies are necessary to reveal the time-dependent effects of the T4 sequence on transgene expression from plasmid DNAs delivered in the naked and complexed forms.
In addition, the effects of the T4 sequence were quantitatively different with these carriers. For example, more than 10-fold higher levels of luciferase were produced from pLHC4/TLN-6 and pLHC4/TLN-16, as compared to the level of pST0/TLN-7 with TransIT-LT1 at 72 hr, and the levels was only ~3.5-fold higher with Lipofectamine at the same time point (Figs. 2 and 3) . The increase in the transgene expression was larger with the former reagent than with the latter at 48-96 hr. Lipofectamine and 13
TransIT-LT1 seemed to affect the expression efficiencies per single copy of the transgene differently for both plasmid DNAs. In the case of pLHC4/TLN-6, the expression efficiencies were comparable for the two reagents at 48 hr ( Table 2 ). The expression efficiencies from pLHC4/TLN-16 with Lipofectamine were higher than those with
TransIT-LT1. These differences suggest that the carriers affected the intranuclear disposition of the delivered plasmid DNAs in COS-7 cells.
Recently, we administered the same plasmid DNAs in a naked 2.4 (±0.2) X 10 -3 *** pLHC4/TLN-6 1.8 (±1.1) X 10 -3 * 6.0 (±2.7) X 10 -3 * 7.8 (±7.6) X 10 -3 * 3.2 (±1.0) X 10 -3 ** a The luciferase activities shown in Figs. 1 and 2 were divided by the DNA amounts at the same time points shown in Table 1 .
The values represent the averages (±SD) of three separate experiments, except for one sample (Lipofectamine, pLHC4/TLN-16, 24 hr, n=2).
(*P<0.05, **P<0.01, and ***P<0.001 versus pST0/TLN-7).
